Antineoplastics/rituximabLack of efficacy: 2 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1981卷 / 1期

关键词：

D O I：

10.1007/s40278-023-48632-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：53 / 53

相关论文

共 50 条

[41] Immune-globulin/methylprednisolone/rituximabLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1962 (1) : 217 - 217
[42] Antineoplastics/immunosuppressanntsFulminant hepatitis and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1891 (1) : 44 - 44
[43] Antineoplastics/voriconazoleCurvularia sinusitis and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1914 (1) : 79 - 79
[44] Antineoplastics/baltaleucel-TLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1984 (1) : 83 - 83
[45] Azathioprine/mycophenolate-mofetil/rituximabLack of efficacy: 2 case reports
Reactions Weekly, 2021, 1872 (1) : 80 - 80
[46] Antineoplastics/immunotherapiesDrug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1963 (1) : 84 - 84
[47] Antineoplastics/immunosuppressantsLack of efficacy: 4 case reports
Reactions Weekly, 2022, 1928 (1) : 60 - 60
[48] Antineoplastics/bevacizumabLack of efficacy: 3 case reports
Reactions Weekly, 2022, 1913 (1) : 73 - 73
[49] Antineoplastics/timololLack of efficacy: 4 case reports
Reactions Weekly, 2023, 1962 (1) : 60 - 60
[50] Antineoplastics/epirubicinLack of efficacy: 3 case reports
Reactions Weekly, 2022, 1927 (1) : 78 - 78

← 1 2 3 4 5 →